Highlights
- A treatment consisting of vascular endothelial growth factor fused to a bioengineered carrier promotes the recovery of kidney function in pigs with a disease frequently observed in patients in which the kidneys' arteries are blocked.
Washington, DC (November 5, 2015) -- A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).